TRT(SH:600085) Nan Fang Du Shi Bao·2025-12-24 23:15Core Viewpoint - A product marketed as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" by Sichuan Health Pharmaceutical Co., Ltd. was found to have a phospholipid content of 0%, despite being labeled as 43%, raising concerns of product fraud [3][4][6]. Group 1: Company Response - After the fraud allegations, Tongrentang Group initiated a zero-tolerance brand management action, including a comprehensive investigation of the involved products and a directive to remove them from sale [7][8]. - The group stated it would pursue legal action against Sichuan Health and other involved parties for trademark infringement and misleading consumers [6][7]. - The company emphasized the need for accountability within its subsidiaries and announced a thorough review of brand usage across its enterprises [7][9]. Group 2: Regulatory and Market Oversight - The Shanghai Consumer Protection Committee conducted tests on 15 popular Antarctic krill oil products, leading to the discovery of the fraudulent labeling [4][5]. - Regulatory bodies, including the Chengdu New District Market Supervision Administration, have launched investigations into the matter and have initiated legal proceedings against the involved companies [8][9]. - The committee has expressed the expectation for Tongrentang Group to implement corrective measures effectively [8]. Group 3: Legal Implications - Legal experts indicated that if the sales amount exceeds 50,000 yuan, the involved parties could face criminal charges for selling counterfeit goods [5][10]. - The concept of "apparent agency" suggests that Tongrentang Group may bear joint liability for the actions of its subsidiary, as the product prominently featured the Tongrentang brand [17][19]. - Previous incidents involving Tongrentang's subsidiaries have raised questions about the company's internal governance and oversight mechanisms [12][13].